Actively Recruiting
PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors
Led by Affiliated Hospital of Jiangnan University · Updated on 2025-01-22
30
Participants Needed
1
Research Sites
107 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To investigate the biological distribution of a new tracer 68Ga-FAPI-JNU in the primary, metastatic and normal tissues of patients with malignant tumors, and to evaluate the biological distribution of 68GA-FAPI-JNU with standardized uptake values.
CONDITIONS
Official Title
PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects must voluntarily sign informed consent and be able to complete the study as required
- Age between 18 and 85 years, male or female
- Clinically diagnosed with a malignant tumor confirmed by biopsy or imaging such as CT or MRI
- ECOG performance status score between 0 and 3
You will not qualify if you...
- History of allergy or allergic constitution to any component of the tracer, including alcohol
- Pregnant or breastfeeding women
- History of mental illness or related conditions
- Unable or unwilling to undergo PET/CT scanning
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Affiated Hospital of Jiangnan University
Wuxi, Jiangsu, China, 214000
Actively Recruiting
Research Team
C
chunjing Yu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here